Early Specialized Cardiovascular Intervention Based on Impedance Cardiography in Locally Advanced Non-small Cell Lung Cancer Patients

Inclusion Criteria: 1. It is diagnosed as non-small cell lung cancer by pathological examination or cytological examination; it is assessed as locally advanced, unresectable stage III non-small cell lung cancer by imaging; 2. Plan to receive radical radiotherapy and chemotherapy ± immunotherapy; 3. Male or female between 18 and 75 years old; 4. Life expectancy ≥ 12 weeks; 5. The World Health Organization (WHO) PS score is 0 or 1; 6. Organ and bone marrow function meet the following conditions: Forced expiratory volume per second (FEV1) ≥1000 ml; absolute neutrophil count ≥1.5×10\^9/L; platelets ≥100×10\^9/L; hemoglobin ≥90 g/L ; Serum creatinine clearance calculated according to the Cockcroft-Gault formula ≥50 mL/min (Cockcroft and Gault 1976); serum bilirubin ≤1.5 times the upper limit of normal (ULN); alanine aminotransferase and aspartate aminotransferase ≤2.5 times ULN; 7. A signed informed consent form is required before proceeding with any step in the research; 8. There is an abnormality in the initial cardiac output index. Exclusion Criteria: 1. PS score 2-4; 2. Organ function impairment: FEV1 \<1000ml; absolute neutrophil count \<1.5×10\^9/L; platelets \<100×10\^9/L; hemoglobin \<90 g/ L; Serum creatinine clearance calculated according to Cockcroft-Gault formula \<50 mL/min; serum bilirubin\>1.5 times ULN; alanine aminotransferase and aspartate aminotransferase\>2.5 times ULN; 3. Unstable angina or myocardial infarction occurred in the past month; 4. Arrhythmia that has not been controlled and can cause symptoms or abnormal hemodynamics; 5. Active endocarditis; 6. Symptomatic severe aortic stenosis; 7. Heart failure that has not been controlled; 8. Acute pulmonary embolism, pulmonary infarction or low thrombosis (artery or vein) formation; 9. Suspected or confirmed aortic dissection; 10. Uncontrolled bronchial asthma; 11. Pulmonary edema; 12. Fingertip blood oxygen saturation at rest ≤85%; 13. Acute non-cardiopulmonary diseases (such as infection, renal failure, thyrotoxicosis, etc.) that may affect sports performance or aggravate due to exercise; 14. Mental disorders make it impossible to cooperate. 15. Patients for whom drug intervention is clearly recommended according to the 2022 edition of the European Society of Cardiology Guidelines on Cardio-Oncology.